Back to search

University of Birmingham

Investigating the immunosuppressive microenvironment created by acute myeloid leukaemia using invariant natural killer T cells as a novel therapeutic approach

Abstract

dc:description.abstract

Acute myeloid leukaemia (AML) creates an immunosuppressive microenvironment to conventional T cells through Arginase 2 (ARG2) inducing arginine depletion. We identify that AML blasts release the acute phase protein serum amyloid A (SAA), which acts in an autocrine manner to upregulate ARG2 expression and activity and promote AML blast viability. Invariant natural killer T cells (iNKT) are a distinct population of T-cells with the unique ability to bridge the innate and adaptive immune system by mediating a range of immune responses and play a key role in tumour immunosurveillance. In AML the low level of iNKT cells post stem cell transplant is associated with poor overall survival; however it is unclear if iNKT cells directly regulate the growth of malignant cells. We establish that iNKT cells can detect and interact with AML blasts in a CD1d/CD40 dependent manner. α-GalCer-loaded AML blasts induce potent iNKT cell activation resulting in release IFN-γ and initiating clonal expansion in vivo and in vitro. Activated iNKT cells can reduce tumour burden by directly killing AML blasts via granzyme B pathway inducing apoptosis. Despite the low arginine AML microenvironment which is hostile to T cells, iNKT cells retain their ability to proliferate, become activated and elicit a cytotoxic response against AML due to the upregulation of LAT-1 and ASS-1 dependent amino acid pathways. Finally, activated iNKT cells can further restore T cell proliferation both in vitro and in vivo. This illustrates that iNKT cells are key players in creating an anti-leukemic response, thus, stimulation of iNKT cell activity has the potential to be exploited as an immunotherapeutic approach against AML or as an adjunct to boost antigen-specific T cell immunotherapies in cancers.

Degree

thesis:*
Name dc:type.qualificationname
d_ph
Level dc:type.qualificationlevel
d_ph
Grantor dc:publisher.institution
University of Birmingham
Year dc:date.issued
2022

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Stavrou, Victoria

Subjects

dc:subject × 1

Rights

Language dc:language.dcterms_iso639_2
eng

Chain of custody

source
Harvested from
University of Birmingham
Base URL
etheses.bham.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Stavrou, Victoria. Investigating the immunosuppressive microenvironment created by acute myeloid leukaemia using invariant natural killer T cells as a novel therapeutic approach. d_ph thesis, University of Birmingham, 2022.